SEHK:9863
SEHK:9863Auto

Should Leapmotor’s Addition to the Hang Seng TECH Index Prompt Action From SEHK:9863 Investors?

Zhejiang Leapmotor Technology recently announced its inclusion as a constituent stock of the Hang Seng TECH Index, effective December 8, 2025, marking an important recognition of its innovations in the technology and new energy vehicle space. This development is anticipated to expand the company's investor base, improve trading liquidity, and increase market visibility among global investors. We'll examine how Leapmotor's upcoming addition to the Hang Seng TECH Index could reinforce its...
SEHK:1177
SEHK:1177Pharmaceuticals

China Approves LM-350 Clinical Trials; Could Be a Game Changer for Sino Biopharm (SEHK:1177)

On November 18, 2025, Sino Biopharmaceutical announced that its subsidiary LaNova Medicines received clinical trial approval in China for LM-350, a CDH17-targeting antibody-drug conjugate aimed at treating multiple gastrointestinal cancers. This regulatory milestone marks further progress in Sino Biopharmaceutical's efforts to address significant unmet medical needs in the oncology sector through its innovative pipeline. We’ll examine how this clinical trial approval for LM-350 shapes Sino...
SEHK:6181
SEHK:6181Luxury

Laopu Gold's Dividend Policy Approval Might Change The Case For Investing In Laopu Gold (SEHK:6181)

On November 18, 2025, Laopu Gold Co., Ltd. announced shareholder approval of an interim dividend of RMB 9.59 per share for the first half of the year, with payment scheduled for January 15, 2026 in both RMB and HKD to eligible shareholders. The approval of a formal dividend policy and amendments to the Articles of Association signify the company's focus on enhanced shareholder returns and governance practices. We will explore how the establishment of a consistent dividend policy shapes Laopu...
SEHK:3939
SEHK:3939Metals and Mining

A Look at Wanguo Gold Group (SEHK:3939) Valuation Following Gold Ridge Mine Feasibility Study Release

Wanguo Gold Group (SEHK:3939) just released a thorough summary of the Gold Ridge Mine feasibility study in the Solomon Islands, outlining both geology and resource estimates. The project’s scale and development prospects present intriguing implications for shareholders. See our latest analysis for Wanguo Gold Group. Wanguo Gold Group’s recent announcement about the Gold Ridge Mine has sparked renewed investor enthusiasm, with the share price rallying 5.08% in just one day and climbing more...
SEHK:6618
SEHK:6618Consumer Retailing

JD Health (SEHK:6618): Valuation Insights Following New Partnership to Boost Chronic Disease Services and Online Reach

JD Health International (SEHK:6618) has partnered with ClouDr Group Limited to expand its online sales presence and improve chronic disease management services. The collaboration aims to combine the scale of JD Health with the specialized medical expertise of ClouDr. See our latest analysis for JD Health International. JD Health International’s latest partnership comes on the heels of a stellar run, with its share price soaring 135.61% year-to-date. While there has been a modest dip over the...
SEHK:823
SEHK:823Retail REITs

Assessing Link REIT (SEHK:823) Valuation Following Latest Earnings and Interim Distribution Update

Link Real Estate Investment Trust (SEHK:823) just released earnings for the half year through September 2025, showing a narrower loss compared to last year but also revealing a slight dip in sales. Alongside the results, an interim distribution was announced with important payout dates for unitholders. See our latest analysis for Link Real Estate Investment Trust. After a tough week that saw Link Real Estate Investment Trust’s share price slide more than 12%, recent earnings and a new interim...
SEHK:9926
SEHK:9926Biotechs

Does Akeso’s (SEHK:9926) First Alzheimer’s Bispecific Antibody Approval Reinvent Its Innovation Narrative?

Earlier this month, Akeso, Inc. announced that its novel bispecific antibody AK152 received approval from the National Medical Products Administration (NMPA) to begin clinical trials for Alzheimer's Disease, marking the first such therapy of its kind developed in China for disease modification. This milestone also signifies Akeso's entry into innovative central nervous system therapeutics, leveraging enhanced brain penetration and robust preclinical results for potential next-generation...
SEHK:354
SEHK:354IT

Chinasoft’s OpenHarmony and RISC-V Alliance Might Change the Case for Investing in Chinasoft (SEHK:354)

Chinasoft International recently announced a strategic cooperation agreement with Shenzhen Kaihong Digital Industry Development and Beijing ESWIN Computing Technology to co-develop a dual-open-source ecosystem based on "OpenHarmony + RISC-V." This alliance aims to create a comprehensive domestic software-hardware ecosystem that could challenge existing global technology architectures and standards. We’ll explore how this push into an independent "OpenHarmony + RISC-V" platform could shape...
SEHK:551
SEHK:551Luxury

The Bull Case For Yue Yuen Industrial (Holdings) (SEHK:551) Could Change Following Nine-Month Earnings Decline and Slower Sales

Yue Yuen Industrial (Holdings) Limited recently reported earnings for the nine months ended September 30, 2025, with sales of US$6.02 billion and net income of US$278.72 million, both reflecting a decrease compared to the prior year. Lower profitability and revenue raise questions about challenges in the company's core footwear and manufacturing operations during the reporting period. We’ll explore how the earnings decline and subdued sales tempo could shape investor perspectives on Yue Yuen...
SEHK:179
SEHK:179Auto Components

Does Johnson Electric (SEHK:179) Prioritize Payouts Over Growth Following Resilient Profits and Dividend News?

Johnson Electric Holdings Limited recently reported its half-year earnings, revealing sales of US$1.83 billion and a net income of US$133.26 million, alongside the declaration of an interim dividend of HK$0.17 per share for the six months ended September 30, 2025. A notable aspect is that net income edged higher despite a slight decrease in sales from the prior year, highlighting the company's profit resilience. With the interim dividend announcement underscoring continued shareholder...
SEHK:8349
SEHK:8349Chemicals

Asian Penny Stock Spotlight: Chaoju Eye Care Holdings And Two More Opportunities

Amidst global market fluctuations driven by AI concerns and valuation anxieties, investors are increasingly exploring diverse opportunities across different regions, including Asia. While the term 'penny stock' might evoke images of speculative ventures from the past, these smaller or newer companies can still offer valuable prospects when supported by solid financials. In this article, we highlight three Asian penny stocks that combine balance sheet strength with potential for growth,...
SEHK:2618
SEHK:2618Logistics

Will JD Logistics' Management Change Signal a Shift in Its Margin Strategy? (SEHK:2618)

On November 13, 2025, JD Logistics announced that Mr. Zhenhui Wang would become chief executive officer and executive director, replacing Mr. Wei Hu, who is taking on new responsibilities within JD Group, alongside the release of third quarter earnings showing sales of CNY 55.08 billion and net income of CNY 2.03 billion. An interesting detail is that Mr. Wang previously held the chief executive role at JD Logistics, bringing deep industry experience and familiarity with the company during a...